An open label, prospective, non-comparative, multicentre study to assess the safety and efficacy of Etanercept for injection 25 mg in patients with moderate to severe active rheumatoid arthritis.
Phase of Trial: Phase III
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 06 Mar 2011 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 24 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 08 Feb 2010 New trial record